ENANTA PHARMACEUTICALS INC
ENTANASDAQ🏆 #2911 by market capEarnings Nov 16US Equity
$13.48▼ $0.04 (−0.33%)
Live1h▼ 0.4%
24h▼ 0.3%
7d▲ 2.0%
14d▲ 8.3%
30d▼ 1.6%
1y▲ 96.7%
🏦Market Cap
$392M
Small Cap
📈Revenue Growth (YoY)
-3.4%
Declining
📊Gross Margin
98.2%
High
💵FCF Margin
-56.6%
Thin
⚖️P/S Ratio
6.0x
Fair
Otter Score
55
Weak
Earnings
Q3 · 2026Reported 2026-08-10Earnings Per Share
Actual
-0.67
Expected
-0.51
miss
−31.50%
YoY +21.20%
Revenue
Actual
$14.36M
Expected
$16.76M
miss
−14.30%
YoY −21.60%
Consensus estimates
Recent quarters
Q3 2026
-0.67
miss
Q2 2026
-0.45
beat
Q1 2026
-0.42
beat
Q4 2025
-0.87
beat